Hyperuricemia is a common finding in preeclamptic pregnancies. It often precedes clinical manifestations of the disease, including reduced glomerular filtration. 1, 2 The serum uric acid level has also been reported to correlate with disease severity and perinatal mortality. 1, 3 The mechanism for the increased serum uric acid in preeclampsia has historically been attributed to reduced excretion of uric acid in the proximal tubules secondary to hypovolemia. Although hypovolemia is a change that occurs early in the development of preeclampsia, 4, 5 the increase in uric acid precedes the reduction in plasma volume. 6 Recently, increased oxidative stress and the formation of reactive oxygen radicals have been proposed as other sources of the elevated serum uric acid seen in preeclampsia. 3, [7] [8] [9] Uric acid is the final product of purine metabolism: the result of hypoxanthine and xanthine degradation by xanthine dehydrogenase and xanthine oxidase. In the setting of ischemia, xanthine dehydrogenase is converted to its oxidase form, xanthine oxidase. 10 Purine metabolism by xanthine oxidase couples the production of uric acid with the generation of superoxide anion (O 2 − ) and hydrogen peroxide (H 2 O 2 ). Both of these compounds have been implicated in ischemia-reperfusion injury. 10 In preeclampsia, the expression of the xanthine dehydrogenase/xanthine oxidase holoenzyme and the activity of xanthine oxidase have been shown to be increased in a subpopulation of cytotrophoblasts. 11 Thus, many authors have proposed that the increased serum uric acid directly promotes oxidative stress and endothelial dysfunction, two central pathophysiological features of preeclampsia. [7] [8] [9] However, the relationship between uric acid and superoxide generation has yet to be studied in preeclampsia.
In this study, we investigated whether serum uric acid level correlated with superoxide generation and oxidative stress in preeclampsia. We assessed the levels of serum uric acid, plasma H 2 O 2 , and plasma protein carbonyl, a sensitive biomarker for reactive oxygen radical-mediated protein damage, 12 in normal and preeclamptic pregnancies. 
Methods

Study
Background
Increased serum uric acid has been postulated to directly promote oxidative stress. The aim of this study was to investigate whether serum uric acid level correlated with superoxide generation and oxidative stress in preeclampsia.
Methods
We assessed serum uric acid levels, plasma hydrogen peroxide levels, and plasma protein carbonyl levels in normal pregnant (n = 14) and preeclamptic women (n = 17). Serum uric acid and plasma hydrogen peroxide levels were determined by the uricase-peroxidase method, a combined enzymatic-colorimetric method. Plasma carbonyl levels were measured by ELISA.
results
The mean serum uric acid values were significantly elevated in preeclampsia (6.6 ± 1.5 mg/dl) compared with normal pregnancy (4.0 ± 0.7 mg/dl) (P < 0.001). Plasma protein carbonyl levels were also significantly elevated in preeclampsia (7.72 ± 4.10 nmol/mg) compared with normal pregnancy (2.85 ± 3.06 nmol/mg) (P = 0.0011). In addition, the plasma hydrogen peroxide levels were significantly higher in preeclampsia (66.9 ± 10.9 μmol/l) compared with normal pregnancy (50.1 ± 5.6 μmol/l) (P < 0.001). Serum uric acid levels correlated significantly and positively with plasma hydrogen peroxide levels (r 2 = 0.2965, P = 0.0027) and plasma protein carbonyl levels (r 2 = 0.2011, P = 0.0129).
conclusion
The increased serum uric acid levels correlated closely with plasma hydrogen peroxide levels and plasma protein carbonyl levels in preeclampsia. Therefore, the serum uric acid level serves as an indicator of the underlying oxidative stress in preeclampsia. Pregnancy. 13 The diagnostic criteria included a blood pressure >140/90 mm Hg and >300 mg of protein in a 24-h urine collection. Women in active labor were excluded. All subjects were nonsmokers without a history of hypertension or diabetes mellitus. The two groups of pregnant women were matched for age, prepregnancy body mass index, parity, and gestational age at the time of sampling. Three of the 17 women with preeclampsia received the antihypertensive medication, hydralazine hydrochloride at the time of sampling. Mothers were cared for in the Maternity and Perinatal Care Unit, Kyushu University Hospital. The Institutional Ethics Committee approved the study, and all subjects gave informed consent before participation. Procedures were in accordance with institutional guidelines.
Measurements of uric acid, H 2 O 2 and protein carbonyl levels.
The serum fraction obtained from each subject was separated by centrifugation and the samples were processed immediately. Serum uric acid levels were determined by the uricaseperoxidase method (Determiner-L UA; Kyowa Medex, Tokyo, Japan) using an autoanalyzer (Hitachi 7600; Hitachi, Tokyo, Japan). The plasma fraction, obtained from each subject, was separated by centrifugation, filtered with a 22 μm filter (MilliPore, Bedford, MA) and stored at −80 °C until each test was conducted. Plasma H 2 O 2 was measured using a commercially available colorimetric assay kit (Northwest Life Science Specialties, Vancouver, WA). The assay is based on the oxidation of ferrous iron Fe 2+ to ferric Fe 3+ by peroxides and the subsequent reaction with xylenol orange to form a purple complex. 14 The assay has an intra-assay variation of 5%, an interassay variation of 5%, and a sensitivity of 1.5 μmol/l. Plasma protein carbonyl was measured using a commercially available specific ELISA kit (BIOCELL, Auckland, New Zealand). This assay has an intra-assay variation of 5%, an interassay variation of 5% and a sensitivity of 0.1 nmol/mg.
Statistical analysis.
Results are expressed as the mean ± s.d. Statistical comparisons between the two groups were made with the unpaired t-test using the computer software program JMP 7 (SAS International, Cary, NC). To determine the correlation between serum uric acid and plasma H 2 O 2 levels or protein carbonyl levels, we performed a linear regression analysis by the least squares method using JMP 7. We also performed multiple linear regression analysis of serum uric acid levels with maternal systolic and diastolic blood pressure, plasma H 2 O 2 levels and protein carbonyl levels. A P value <0.05 was considered significant.
results
Clinical data for the women with normal pregnancies and women with preeclampsia are summarized in Table 1 . The mean levels of systolic blood pressure, diastolic blood pressure, and serum creatinine in preeclampsia were significantly higher than those in normal pregnancies. At 4 weeks postpartum, blood pressures and renal functions, such as proteinuria, and serum creatinine and uric acid levels had returned to normal in all women with preeclampsia.
The mean serum uric acid values were significantly elevated in preeclampsia (6.6 ± 1.5 mg/dl) compared with normal pregnancy (4.0 ± 0.7 mg/dl) ( Table 2) . Plasma protein carbonyl levels were also significantly elevated in preeclampsia (7.72 ± 4.10 nmol/mg) compared with normal pregnancy (2.85 ± 3.06 nmol/mg). In addition, the plasma H 2 O 2 levels were significantly higher in preeclampsia (66.9 ± 10.9 μmol/l) compared with normal pregnancy (50.1 ± 5.6 μmol/l).
There was a significant positive correlation between serum uric acid levels (mg/dl) and plasma H 2 O 2 levels (μmol/l). The correlation is described by the following equation: H 2 O 2 = 3.6602 × serum acid + 38.58, r 2 = 0.2965, P = 0.0027 (Figure 1) . Serum uric acid levels (mg/dl) and plasma protein carbonyl levels (nmol/mg) were also significantly and positively correlated. The equation representing this correlation is: protein carbonyl = 1.1018 × serum acid − 0.4279, r 2 = 0.2011, P = 0.0129. In multiple linear regression models, maternal diastolic blood pressure levels (r 2 = 0.3482, P = 0.0062) or plasma H 2 O 2 levels (r 2 = 0.2763, P < 0.0001) remained associated with serum uric acid levels. The placenta plays a major role in the pathogenesis of preeclampsia, as evidenced by the increased incidence of preeclampsia in women with abnormal placentation and reduced placental perfusion. 15, 16 Reduced placental perfusion results in an ischemia-reperfusion injury to the placenta and oxidative damage. Placental ischemia and oxidative damage lead to widespread activation and/or dysfunction of the maternal vascular endothelium, which has been implicated as a cause of the clinical abnormalities in preeclampsia. There is indirect evidence of increased reactive oxygen radicals production in the placental tissue of preeclamptic women, 17 and direct evidence of local oxidative stress with increased formation of nitrotyrosines 18 and protein carbonyls. 19 Ischemic injury and oxidative stress promote a feed-forward cycle of uric acid production. With tissue injury, purines are liberated, and with hypoxia ATP is degraded to both adenine and xanthine. In addition, hypoxia is a potent inducer of the xanthine dehydrogenase/xanthine oxidase holoenzyme and preferentially increases the oxidase form of the enzyme. 10 In preeclampsia, induction of placental xanthine oxidase activity 11 and increased plasma adenosine levels 20 have been demonstrated. The results of these studies suggest that the increased serum uric acid directly promotes oxidative stress in preeclampsia. Despite evidence supporting oxidative stress in preeclamptic placentas, 11, [17] [18] [19] a conclusive relationship between systemic oxidative stress and serum uric acid levels in preeclampsia has not been established.
In this study, mean serum uric acid levels, plasma H 2 O 2 levels, and plasma protein carbonyl levels were significantly higher in women with preeclampsia than in normal pregnant women.
These findings are consistent with previous studies. 3, 21, 22 Furthermore, there were positive correlations between serum uric acid levels and both plasma H 2 O 2 levels and plasma protein carbonyl levels regardless of the presence of preeclampsia. These findings suggest that the serum uric acid level is a measurable indicator of the underlying oxidative stress in preeclampsia.
Kharfi et al. 22 reported a significant positive correlation between serum human chorionic gonadotropin and H 2 O 2 levels in preeclampsia. Human chorionic gonadotropin secretion into the maternal circulation may be increased as a consequence of abnormal placental invasion, 23 or placental hypoxia with the development of a hypersecretory state. 24 These findings suggest that increased serum uric acid and systemic oxidative stress may be caused by placental ischemia. Alternatively, maternal tissues may also experience ischemic injury due to vasospasm secondary to endothelial dysfunction. Maternal ischemic injury is also related to elevated uric acid. We have previously obtained direct evidence of neutrophil-mediated endothelial cell damage in vitro. 25 In preeclampsia, the dominance of neutrophil O 2 − production over nitric oxide production results in elaboration of the O 2 − derivatives, H 2 O 2 , and peroxynitrite, both of which directly damage endothelial cells. In this study, we did not investigate the source of the uric acid and oxidative stress in the maternal circulation. Therefore, we were unable to establish a causal relationship between increased serum uric acid levels and oxidative stress.
The xanthine oxidase inhibitor allopurinol and its active metabolite oxypurinol have been shown to have beneficial effects in experimental animal models and in small-scale human clinical trials for the treatment of various forms of tissue and vascular injury. Injuries were mediated by conditions such as ischemia, inflammatory diseases, and chronic heart failure. 26, 27 To date, there is only one trial in which allopurinol has been administered to women with severe preeclampsia diagnosed between 24 and 32 weeks of gestation. 28 This study allocated the preeclamptic women randomly to groups to receive either 200 mg allopurinol with vitamins E and C, or placebo. The allopurinol group had a longer interval to delivery, but there were no differences in maternal complications or fetal outcomes. Serum lipid peroxide levels were not significantly altered in either the allopurinol or the placebo group. However, in this study the serum uric acid levels during allopurinol treatment only decreased from 0.37 mmol/l (6.2 mg/dl) before treatment to 0.32 mmol/l (5.4 mg/dl) at delivery. Hence this study does not adequately address the issue of whether decreasing uric acid levels can lead to a decrease in oxidative stress. We believe that evaluation of this question may establish a causal relationship between increased serum uric acid levels and oxidative stress. Identification of such a relationship may lead to the development of new interventions designed to prevent and treat preeclampsia.
This study provides conclusive evidence of a relationship between uric acid levels and oxidative stress in the maternal circulation of preeclamptic women. Plasma hydrogen peroxide and protein carbonyl levels were elevated in preeclampsia and correlated closely with serum uric acid levels. Therefore, serum uric acid levels may be used as an indicator of the underlying oxidative stress in preeclampsia. articles Hyperuricemia, Oxidative Stress, and Preeclampsia
